Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis
Pediatric Nephrology · 2026
DOI: 10.1007/s00467-026-07441-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Nephrology, 2026. Verfasst von Bingyang Bie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450099, Henan, China. Hauptthemen laut MEDLINE: Kidney, Glomerulonephritis, IGA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Foundation of Henan Educational Committee.
Abstract (Originalsprache)
BACKGROUND: For pediatric patients with IgA vasculitis nephritis (IgAVN), therapeutic decisions during relapse are often guided by empirical adjustments based on clinical manifestations, lacking timely pathological evidence. We aimed to investigate the dynamic evolution of kidney pathology in children with IgAVN and evaluate the clinical utility of repeat kidney biopsy in treatment decisions. METHODS: Retrospective analysis was conducted on 30 children with IgAVN who underwent repeat kidney biopsy. We summarized demographic characteristics, clinical relapse features, and indications for repeat kidney biopsy. Clinical indicators and kidney pathological changes were compared from initial to repeat kidney biopsy, and correlation between clinical indicators and pathological progression was analyzed. Longitudinal progression after treatment adjustments based on repeat kidney biopsy findings was assessed using linear mixed-effects model (LMM). RESULTS: Median interval between the two kidney biopsies was 39.95 months. During this period, despite no significant changes in 24-h urinary protein (24 h UTP) and urinary red blood cell (URBC) levels, estimated glomerular filtration rate (eGFR) showed a slight increasing trend (141.68 vs. 167.37 mL/min/1.73 m2, P = 0.031). In contrast, pathological findings revealed significant deterioration of ISKDC grades (P 0.05); only fluctuations in eGFR correlated with global sclerosis progression (P = 0.019). Consequently, 80.00% of children had treatment regimen adjustment based on repeat biopsy results. Following adjustments, both 24 h UTP (P < 0.001) and URBC (P < 0.001) decreased significantly, while serum creatinine (SCr) levels remained stable (P = 0.109), indicating a positive therapeutic response. CONCLUSION: A distinct dissociation exists between clinical presentation and kidney pathological progression during relapse in children with IgAVN. Repeat kidney biopsy is particularly beneficial for pediatric patients with clinical relapse whose conditions cannot be accurately assessed by conventional indicators; it facilitates enhanced treatment precision and improves long-term kidney outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450099, Henan, China.
- School of Pediatrics, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China.
- Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450099, Henan, China. zhangjiantg@126.com.
- School of Pediatrics, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China. zhangjiantg@126.com.
Förderung
- Foundation of Henan Educational Committee
Zitieren
APA
Bie, B., Ding, X., Zhang, J., Yang, X., He, F., Wang, F., Ran, S., & Li, J. (2026). Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07441-0
Vancouver
Bie B, Ding X, Zhang J, Yang X, He F, Wang F, et al. Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis. Pediatric Nephrology. 2026. doi:10.1007/s00467-026-07441-0
BibTeX
@article{Bie2026,
author = {Bie, Bingyang and Ding, Xueying and Zhang, Jian and Yang, Xiaoqing and He, Fangfang and Wang, Fangyu and Ran, Siqi and Li, Jiaxin},
title = {Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis},
journal = {Pediatric Nephrology},
year = {2026},
doi = {10.1007/s00467-026-07441-0}
}
EUVIMED